About Sorafenib Tosilate
Class: | Antineoplastic agent, Tyrosine kinase inhibitor
Use: | Treatment of advanced renal cell carcinoma (RCC), unresectable hepatocellular carcinoma (HCC), and differentiated thyroid carcinoma (DTC)
Adult dose: | 400 mg orally twice daily, taken on an empty stomach
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Diarrhea, hypertension, fatigue, hand-foot skin reaction, rash, nausea, vomiting, and liver function abnormalities
Contraindicati
Important Warnings
Risk of severe bleeding, cardiovascular events, and hepatotoxicity; monitor liver function and blood pressure regularly; avoid use in patients with active bleeding or significant cardiovascular disease
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.